[Traumatic brain injury: neurologic and psychiatric aspects]

Area of Science:

• Neurology
• Neuroscience
• Public Health

Background:

• Traumatic brain injury (TBI) is a major cause of death, disability, and health decline in young individuals.
• TBI commonly results in neurological and psychiatric disorders, particularly neurocognitive impairment.
• Existing therapeutic interventions focus on acute phase management, neurocognitive deficits, and mental health symptoms.

Purpose of the Study:

• To address the unmet need for effective treatments for neurocognitive deficits following traumatic brain injury.
• To explore and identify new medicines and therapeutic approaches for improving outcomes in TBI patients.

Main Methods:

• Review of current therapeutic interventions for traumatic brain injury.
• Analysis of the efficacy of treatments for neurocognitive impairment post-TBI.
• Identification of gaps in current treatment strategies.

Main Results:

• The efficacy of current treatments for neurocognitive deficits associated with TBI is not satisfactory.
• There is a clear and urgent need for the development of new pharmacological agents and therapeutic strategies.

Conclusions:

• Novel therapeutic approaches are essential to improve the management of neurocognitive deficits after traumatic brain injury.
• Further research into new medicines is critical to enhance recovery and reduce long-term disability from TBI.